Literature DB >> 11298929

In vitro activity of propyl gallate-azole drug combination against fluconazole- and itraconazole-resistant Candida albicans strains.

F D D'Auria1, M Tecca, R Strippoli, N Simonetti.   

Abstract

AIMS: The influence of an antioxidant, propyl gallate (PG), on the in vitro antifungal activity of itraconazole and fluconazole, was investigated to determine whether PG could increase the antifungal activity and reduce strain resistance. METHODS AND
RESULTS: Susceptibility tests were performed against azole-resistant isolates of Candida albicans by the microbroth dilution method in the presence of PG at 400 microg ml-1. PG-triazole combination brought about a marked reduction of inhibitory azole concentration. In particular, the MIC90 for itraconazole and fluconazole dropped from 1 microg ml-1 to 0.125 microg ml-1 and from > 64 microg ml-1-8 microg ml-1, respectively.
CONCLUSION: It is likely that more than one mechanism is involved in the above synergistic interaction, including effects of PG on ATP synthesis, thus reducing the ABC transporters activity, or an effect on the target of azole, i.e. the P-450 cytochrome. SIGNIFICANCE AND IMPACT OF THE STUDY: The PG-triazole combination may have a role in future topical antifungal strategies but other studies are warranted.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298929     DOI: 10.1046/j.1472-765x.2001.00893.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  6 in total

1.  Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.

Authors:  Hua Quan; Ying-Ying Cao; Zheng Xu; Jing-Xia Zhao; Ping-Hui Gao; Xiao-Feng Qin; Yuan-Ying Jiang
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

2.  A novel polyamide SL-A92 as a potential fungal resistance blocker: synthesis and bioactivities in Candida albicans.

Authors:  Shao-long Zhu; Zhi-hui Jiang; Ping-hui Gao; Yue Qiu; Liang Wang; Yuan-ying Jiang; Da-zhi Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-06-21       Impact factor: 6.150

3.  Activity of gallic acid and its ester derivatives in Caenorhabditis elegans and zebrafish (Danio rerio) models.

Authors:  Junya de Lacorte Singulani; Liliana Scorzoni; Paulo César Gomes; Ana Carolina Nazaré; Carlos Roberto Polaquini; Luis Octávio Regasini; Ana Marisa Fusco-Almeida; Maria José Soares Mendes-Giannini
Journal:  Future Med Chem       Date:  2017-10-27       Impact factor: 3.808

4.  Chemosensitization as a means to augment commercial antifungal agents.

Authors:  Bruce C Campbell; Kathleen L Chan; Jong H Kim
Journal:  Front Microbiol       Date:  2012-02-29       Impact factor: 5.640

Review 5.  Potential Use of Phenolic Acids as Anti-Candida Agents: A Review.

Authors:  Guilherme R Teodoro; Kassapa Ellepola; Chaminda J Seneviratne; Cristiane Y Koga-Ito
Journal:  Front Microbiol       Date:  2015-12-21       Impact factor: 5.640

Review 6.  A Review on Ethnopharmacological Applications, Pharmacological Activities, and Bioactive Compounds of Mangifera indica (Mango).

Authors:  Meran Keshawa Ediriweera; Kamani Hemamala Tennekoon; Sameera Ranganath Samarakoon
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-31       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.